Kynurenic acid: A metabolite with multiple actions and multiple targets in brain and periphery

Journal of Neural Transmission

Volumn 119, Issue 2, 2012, Pages 133-139

  Moroni, Flavio ^a   Cozzi, Andrea ^a   Sili, Maria ^a   Mannaioni, Guido ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

AHR; Glutamate receptors; GPR35; Kynurenine; Nicotinic receptors; NMDA

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; BUNGAROTOXIN RECEPTOR; CYTOKINE; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 35; GLUTAMIC ACID; HIGH MOBILITY GROUP B1 PROTEIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; KYNURENIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; BINDING AFFINITY; CELL FUNCTION; CYTOKINE RELEASE; DRUG RECEPTOR BINDING; EXTRACELLULAR SPACE; GLIA CELL; HUMAN; IMMUNOMODULATION; MACROPHAGE; MEDIATOR RELEASE; MONOCYTE; NERVE CELL; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEPTIC SHOCK; TRANSCRIPTION REGULATION;

ANIMALS; BRAIN; DRUG DELIVERY SYSTEMS; HUMANS; KYNURENIC ACID; NEUROGLIA; PERIPHERAL NERVOUS SYSTEM; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84857627249     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-011-0763-x     Document Type: Review

References (54)

1. L Bacciottini DE Pellegrini-Giampietro F Bongianni G De Luca M Beni V Politi, et al. 1987 Biochemical and behavioural studies on indole-pyruvic acid: a keto-analogue of tryptophan Pharmacol Res Commun 19 803 817 2451257 10.1016/0031-6989(87)90014-2 1:CAS:528:DyaL1cXhtVKgsb0%3D (Pubitemid 18030717)
2. S Campesan EW Green C Breda KV Sathyasaikumar PJ Muchowski R Schwarcz, et al. 2011 The kynurenine pathway modulates neurodegeneration in a Drosophila model of Huntington's disease Curr Biol 21 961 966 21636279 10.1016/j.cub.2011. 04.028 1:CAS:528:DC%2BC3MXntFKmtr8%3D
3. R Carpenedo A Chiarugi P Russi G Lombardi V Carlà R Pellicciari, et al. 1994 Inhibitors of kynurenine hydroxylase and kynureninase increase cerebral formation of kynurenic acid and have sedative and anticonvulsant activities Neuroscience 61 237 244 7969905 10.1016/0306-4522(94)90227-5 1:CAS:528:DyaK2cXmsVGru7g%3D (Pubitemid 24219003)
4. R Carpenedo A Pittaluga A Cozzi S Attucci A Galli M Raiteri, et al. 2001 Presynaptic kynurenate sensitive receptors inhibit glutamate release Eur J Neurosci 13 2141 2147 11422455 10.1046/j.0953-816x.2001.01592.x 1:STN:280:DC%2BD3Mzmt1WqsA%3D%3D (Pubitemid 32578800)
5. R Carpenedo E Meli F Peruginelli DE Pellegrini-Giampietro F Moroni 2002 Kynurenine 3-mono-oxygenase inhibitors attenuate post-ischemic neuronal death in organotypic hippocampal slice cultures J Neurochem 82 1465 1471 12354294 10.1046/j.1471-4159.2002.01090.x 1:CAS:528:DC%2BD38XnsV2hs7o%3D
6. A Chiarugi R Carpenedo F Moroni 1996 Kynurenine disposition in blood and brain of mice: effects of selective inhibitors of kynurenine hydroxylase and of kynureninase J Neurochem 67 692 698 8764597 10.1046/j.1471-4159.1996.67020692.x 1:STN:280:DyaK28zktVWmsw%3D%3D (Pubitemid 26255666)
7. C Cosi G Mannaioni A Cozzi V Carla M Sili L Cavone, et al. 2011 G-protein coupled receptor 35 (GPR35) activation and inflammatory pain: studies on the antinociceptive effects of kynurenic acid and zaprinast Neuropharmacology 60 1227 1231 21110987 10.1016/j.neuropharm.2010.11.014 1:CAS:528: DC%2BC3MXkvVKitbs%3D
8. A Cozzi R Carpenedo F Moroni 1999 Kynurenine hydroxylase inhibitors reduce ischemic brain damage: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3, 4-dimethoxy-[-N-4-(nitrophenyl)thiazol-2yl]-benzensulfonamide (Ro 61-8048) in models of focal or global brain ischemia J Cereb Blood Flow Metab 19 771 777 10413032 10.1097/00004647-199907000-00007 1:CAS:528:DC%2BD3cXksVCqsbk%3D (Pubitemid 30159803)
9. MS Denison SR Nagy 2003 Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals Annu Rev Pharmacol Toxicol 43 309 334 12540743 10.1146/annurev.pharmtox.43.100901.135828 1:CAS:528:DC%2BD3sXitFWqtr8%3D (Pubitemid 37372644)
10. C Di Serio A Cozzi I Angeli L Doria I Micucci S Pellerito, et al. 2005 Kynurenic acid inhibits the release of the neurotrophic fibroblast growth factor (FGF)-1 and enhances proliferation of glia cells, in vitro Cell Mol Neurobiol 25 981 993 16392031 10.1007/s10571-005-8469-y (Pubitemid 43154822)
11. BC DiNatale IA Murray JC Schroeder CA Flaveny TS Lahoti EM Laurenzana, et al. 2010 Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling Toxicol Sci 115 89 97 20106948 10.1093/toxsci/kfq024 1:CAS:528:DC%2BC3cXkvVOgtbw%3D
12. VN Dobrovolsky JF Bowyer MK Pabarcus RH Heflich LD Williams DR Doerge, et al. 2005 Effect of arylformamidase (kynurenine formamidase) gene inactivation in mice on enzymatic activity, kynurenine pathway metabolites and phenotype Biochim Biophys Acta 1724 163 172 15866519 10.1016/j.bbagen.2005.03.010 1:CAS:528:DC%2BD2MXltFGisrg%3D (Pubitemid 40799122)
13. S Erhardt M Hajos A Lindberg G Engberg 2000 Nicotine-induced excitation of locus coeruleus neurons is blocked by elevated levels of endogenous kynurenic acid Synapse 37 104 108 10881031 10.1002/1098-2396(200008)37:2<104::AID- SYN4>3.0.CO;2-L 1:CAS:528:DC%2BD3cXkslOht7g%3D (Pubitemid 30447941)
14. G Faraco S Fossati ME Bianchi M Patrone M Pedrazzi B Sparatore, et al. 2007 High mobility group box 1 protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration in vitro and in vivo J Neurochem 103 590 603 17666052 10.1111/j.1471-4159.2007.04788.x 1:CAS:528:DC%2BD2sXht1KqsL3N (Pubitemid 47498027)
15. A Foster A Vezzani ED French R Schwarcz 1984 Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid Neurosci Lett 48 273 278 6237279 10.1016/0304-3940(84)90050-8 1:CAS:528:DyaL2cXlsVGntLg%3D (Pubitemid 14054435)
16. C Hilmas EFR Pereira M Alkondon A Rassoulpour R Schwarcz EX Albuquerque 2001 The brain metabolite kynurenic acid inhibits α7 nicotinic receptor activity and increases non α7 nicotinic receptor expression: physiopathological implications J Neurosci 21 7463 7473 11567036 1:CAS:528:DC%2BD3MXnsFCksrc%3D (Pubitemid 32904945)
17. H Hirata O Hayaishi 1975 Studies on Indoleamine 2, 3-dioxygenase. Superoxide anion as substrate J Biol Chem 250 5960 5966 238993 1:CAS:528:DyaE2MXlt1yitr4%3D
18. A Homer 1914 The constitution of kynurenic acid J Biol Chem 17 509 518 1:CAS:528:DyaC2cXhvVGlsQ%3D%3D
19. L Jenkins E Alvarez-Curto K Campbell S de Munnik M Canals S Schlyer, et al. 2011 Agonist activation of the G protein-coupled receptor GPR35 involves transmembrane domain III and is transduced via Galpha and beta-arrestin-2 Br J Pharmacol 162 733 748 20958291 10.1111/j.1476-5381.2010.01082.x 1:CAS:528:DC%2BC3MXhslKrtLs%3D
20. G Julou-Schaeffer GA Gray I Fleming C Schott JR Parratt JC Stoclet 1990 Loss of vascular responsiveness induced by endotoxin involves l-arginine pathway Am J Physiol 259 H1038 H1043 2221111 1:CAS:528:DyaK3cXmt1yksLY%3D
21. M Kessler T Terramani G Lynch M Baudry 1989 A glycine site associated with NMDA receptors: characterisation and identification of a new class of antagonist J Neurochem 52 1319 1328 2538568 10.1111/j.1471-4159.1989.tb01881.x 1:CAS:528:DyaL1MXhs1Klur4%3D (Pubitemid 19085960)
22. IP Lapin 1976 Depressor effect of kynurenine and its metabolites in rats Life Sci 19 1479 1484 994696 10.1016/0024-3205(76)90091-6 1:CAS:528: DyaE2sXltVKlsA%3D%3D
23. IP Lapin 1980 Experimental studies on kynurenine as neuroactive tryptophan metabolites: past, present and future Trends Pharmacol Sci 1 410 413 10.1016/0165-6147(80)90066-8 1:CAS:528:DyaL3cXmtlGksLo%3D
24. R Lugo-Huitron T Blanco-Ayala P Ugalde-Muniz P Carrillo-Mora J Pedraza-Chaverri D Silva-Adaya, et al. 2011 On the antioxidant properties of kynurenic acid: Free radical scavenging activity and inhibition of oxidative stress Neurotoxicol Teratol 33 538 547 21763768 10.1016/j.ntt.2011.07.002 1:CAS:528:DC%2BC3MXht1ejsbfJ
25. AH Mehler WE Knox 1950 Conversion of tryptophan to kynurenine in liver II. The enzymatic hydrolysis of formylkynurenine J Biol Chem 187 431 433 14794728 1:CAS:528:DyaG3MXhvFartg%3D%3D
26. JD Mezrich JH Fechner X Zhang BP Johnson WJ Burlingham CA Bradfield 2010 An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells J Immunol 185 3190 3198 20720200 10.4049/jimmunol.0903670 1:CAS:528:DC%2BC3cXhtFSntL7F
27. G Milligan 2011 Orthologue selectivity and ligand bias: translating the pharmacology of GPR35 Trends Pharmacol Sci 32 317 325 21392828 10.1016/j.tips.2011.02.002 1:CAS:528:DC%2BC3MXlvVaisb0%3D
28. F Moroni 1999 Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites Eur J Pharmacol 375 87 100 10443567 10.1016/S0014-2999(99)00196-X 1:CAS:528:DyaK1MXks1Crsro%3D (Pubitemid 29317595)
29. F Moroni P Russi V Carlà G Lombardi 1988 Kynurenic acid is present in the rat brain and its content increases during development and aging processes Neurosci Lett 94 145 150 2468114 10.1016/0304-3940(88)90285-6 1:CAS:528:DyaL1MXhvVyjtA%3D%3D
30. F Moroni P Russi G Lombardi M Beni V Carlà 1988 Presence of kynurenic acid in the mammalian brain J Neurochem 51 177 181 3379401 10.1111/j.1471-4159.1988.tb04852.x 1:CAS:528:DyaL1cXksVyqtLk%3D
31. F Moroni P Russi MA Gallo-Mezo G Moneti R Pellicciari 1991 Modulation of quinolinic and kynurenic acid content in the rat brain: effects of endotoxins and nicotinylalanine J Neurochem 57 1630 1635 1833509 10.1111/j.1471-4159.1991. tb06361.x 1:CAS:528:DyaK3MXmslWht70%3D (Pubitemid 21922799)
32. F Moroni S Fossati A Chiarugi A Cozzi 2007 Kynurenic acid action in brain and periphery Int Congr Series 1304 305 314 10.1016/j.ics.2007.07.016 1:CAS:528:DC%2BD1cXkt1WmtrY%3D
33. H Nemeth H Robotka Z Kis E Rozsa T Janaky C Somlai, et al. 2004 Kynurenine administered together with probenecid markedly inhibits pentylenetetrazol-induced seizures. An electrophysiological and behavioural study Neuropharmacology 47 916 925 15527825 10.1016/j.neuropharm.2004.06.007 1:CAS:528:DC%2BD2cXpsVOmurc%3D (Pubitemid 39440985)
34. NT Nguyen A Kimura T Nakahama I Chinen K Masuda K Nohara, et al. 2010 Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism Proc Natl Acad Sci USA 107 19961 19966 21041655 10.1073/pnas.1014465107 1:CAS:528:DC%2BC3cXhsVyisLzE
35. K Nozaki MF Beal 1992 Neuroprotective effects of l-kynurenine on hypoxia-ischemia and NMDA lesions in neonatal rats J Cereb Blood Flow Metab 12 400 407 1569135 10.1038/jcbfm.1992.57 1:CAS:528:DyaK38XksVShtLo%3D
36. H Ohshiro H Tonai-Kachi K Ichikawa 2008 GPR35 is a functional receptor in rat dorsal root ganglion neurons Biochem Biophys Res Commun 365 344 348 17996730 10.1016/j.bbrc.2007.10.197 1:CAS:528:DC%2BD2sXhtlCrsLvE (Pubitemid 350137295)
37. CA Opitz UM Litzenburger F Sahm M Ott I Tritschler S Trump, et al. 2011 An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor Nature 478 197 203 21976023 10.1038/nature10491 1:CAS:528:DC%2BC3MXht1ylt7nI
38. MN Perkins TW Stone 1982 Specificity of kynurenic acid as an antagonist of synaptic transmission in rat hippocampal slices Neurosci Lett 18 432
39. MC Potter GI Elmer R Bergeron EX Albuquerque P Guidetti HQ Wu, et al. 2010 Reduction of endogenous kynurenic acid formation enhances extracellular glutamate, hippocampal plasticity, and cognitive behavior Neuropsychopharmacology 35 1734 1742 20336058 1:CAS:528:DC%2BC3cXnsVOnsbY%3D
40. F Rossi R Schwarcz M Rizzi 2008 Curiosity to kill the KAT (kynurenine aminotransferase): structural insights into brain kynurenic acid synthesis Curr Opin Struct Biol 18 748 755 18950711 10.1016/j.sbi.2008.09.009 1:CAS:528:DC%2BD1cXhsVOisr%2FJ
41. P Russi V Carlà F Moroni 1989 Indolpyruvic acid administration increases the brain content of kynurenic acid: is this a new avenue to modulate excitatory amino acid receptors in vivo? Biochem Pharmacol 38 2405 2409 2547379 10.1016/0006-2952(89)90083-X 1:CAS:528:DyaL1MXls1Oitrw%3D (Pubitemid 19188402)
42. P Russi M Alesiani G Lombardi P Davolio R Pellicciari F Moroni 1992 Nicotinylalanine increases the formation of kynurenic acid in the brain and antagonizes convulsions J Neurochem 59 2076 2080 1431895 10.1111/j.1471-4159. 1992.tb10097.x 1:CAS:528:DyaK3sXhs1yjuw%3D%3D
43. R Schwarcz WO Whetsell RM Mangano 1983 Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain Science 219 316 318 6849138 10.1126/science.6849138 1:CAS:528:DyaL3sXmvF2gsQ%3D%3D (Pubitemid 13222319)
44. EA Stevens JD Mezrich CA Bradfield 2009 The aryl hydrocarbon receptor: a perspective on potential roles in the immune system Immunology 127 299 311 19538249 10.1111/j.1365-2567.2009.03054.x 1:CAS:528:DC%2BD1MXnvVekt74%3D
45. TW Stone 1993 Neuropharmacology of quinolinic and kynurenic acids Pharmacol Rev 45 309 379 8248282 1:CAS:528:DyaK3sXmtFKltr8%3D (Pubitemid 23292874)
46. KJ Swartz MJ During A Freese MF Beal 1990 Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors J Neurosci 10 2965 2973 2168940 1:CAS:528:DyaK3cXmt1Cru7c%3D
47. F Tarantini I Micucci S Bellum M Landriscina S Garfinkel I Prudovsky, et al. 2001 The precursor but not the mature form of IL1alpha blocks the release of FGF1 in response to heat shock J Biol Chem 276 5147 5151 11087725 10.1074/jbc.C000714200 1:CAS:528:DC%2BD3MXhtlyjsrg%3D
48. C Thiemermann J Vane 1990 Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo Eur J Pharmacol 182 591 595 2226626 10.1016/0014-2999(90)90062-B 1:CAS:528:DyaK3cXlsV2rsLg%3D (Pubitemid 20260783)
49. WA Turski M Nakamura WP Todd BK Carpenter WO Whetsell R Schwarcz 1988 Identification and quantification of kynurenic acid in human brain tissue Brain Res 454 164 169 3409000 10.1016/0006-8993(88)90815-3 1:CAS:528: DyaL1cXks12ktrk%3D
50. L Vecsei MF Beal 1991 Comparative behavioral and pharmacological studies with centrally administered kynurenine and kynurenic acid in rats Eur J Pharmacol 196 239 246 1893912 10.1016/0014-2999(91)90436-T 1:CAS:528: DyaK3MXktVWmsbc%3D
51. L Vecsei J Miller U MacGarvey MF Beal 1992 Kynurenine and probenecid inhibit pentylenetetrazol- and NMDLA-induced seizures and increase kynurenic acid concentrations in the brain Brain Res Bull 28 233 238 1596743 10.1016/0361-9230(92)90184-Y 1:CAS:528:DyaK38XhsVeksLk%3D
52. J Wang N Simonavicius X Wu G Swaminath J Reagan H Tian, et al. 2006 Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35 J Biol Chem 281 22021 22028 16754668 10.1074/jbc.M603503200 1:CAS:528: DC%2BD28XnsVOmsbo%3D (Pubitemid 44181906)
53. P Zhao H Sharir A Kapur A Cowan EB Geller MW Adler, et al. 2010 Targeting of the orphan receptor GPR35 by pamoic acid: a potent activator of extracellular signal-regulated kinase and beta-arrestin2 with antinociceptive activity Mol Pharmacol 78 560 568 20826425 10.1124/mol.110.066746 1:CAS:528:DC%2BC3cXht1eisL3M
54. D Zwilling SY Huang KV Sathyasaikumar FM Notarangelo P Guidetti HQ Wu, et al. 2011 Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration Cell 145 863 874 21640374 10.1016/j.cell.2011.05.020 1:CAS:528:DC%2BC3MXnsVOkt74%3D